MUS
IART icon

Mitsubishi UFJ Securities’s Integra LifeSciences IART Stock Holding History

Mitsubishi UFJ Securities’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-552
Closed -$22K – 224
2016
Q2 		$22K Sell
552
-35,050
-98% -$1.26M 0.04% 140
2016
Q1 		$1.2M Buy
+35,602
New +$1.11M 1.58% 16

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Securities's IART Position: Q3 2016 in Review

Mitsubishi UFJ Securities sold out of Integra LifeSciences (IART) in Q3 2016, closing a stake of 552 shares — an estimated $22K sold.

Mitsubishi UFJ Securities first reported a position in IART in Q1 2016 and held it in 2 quarters. The position peaked at $1.2M in Q1 2016. 234 funds tracked by Wall St. Rank hold IART as of Q3 2016.

  • Mitsubishi UFJ Securities reported no remaining Integra LifeSciences position as of Q3 2016 after selling out during the quarter.
  • Mitsubishi UFJ Securities sold 552 Integra LifeSciences shares in Q3 2016, an estimated $22K.
  • Mitsubishi UFJ Securities first reported a position in Integra LifeSciences in Q1 2016 and held it in 2 quarters.
  • Mitsubishi UFJ Securities's Integra LifeSciences position peaked at $1.2M in Q1 2016.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2016.

Based on Mitsubishi UFJ Securities's 13F filing for Q3 2016, filed 8 Nov 2016.